MEDVi, an online hub for GLP-1 drugs, wants you to know that it's "serious" about helping you lose weight. According to its ...

Sure, I wee like Austin Powers and the number twos are like tennis balls – get comfortable with that idea. But I’m the best ...

Court filings give insight into why shooting suspect Louis Mangione might have targeted the UnitedHealthcare executive: "It checks every box." In other news: Hospital construction trends include AI; ...

The Health Ministry has launched investigations into the rising misuse of Ozempic, which is a diabetes drug, that Kenyans are ...

Surgery risks have been highlighted in a new warning for users of popular diabetes and weight-loss drugs, including Ozempic ...

It's back to the Eastern Conference finals for the Indiana Pacers. The Pacers rallied from an early 19-point deficit to close out the top-seed Cavaliers with a 114-105 Game 5 win in Cleveland.

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

Wegovy and Ozempic are both brand-name versions of the drug semaglutide, but they aren’t exactly the same. The Food and Drug Administration (FDA) has approved Wegovy for weight loss, while ...

Ozempic is a brand name for the medication semaglutide. It’s FDA approved for treating type 2 diabetes by improving blood sugar levels. Licensed healthcare professionals may also prescribe it ...